We can’t show the full text here under this license. Use the link below to read it at the source.
Fecal microbiota transplantation from patients with polycystic ovary syndrome induces metabolic disorders and ovarian dysfunction in germ-free mice
Gut bacteria from women with polycystic ovary syndrome cause metabolism and ovary problems in mice without microbes
AI simplified
Abstract
Mice receiving fecal microbiota from PCOS patients exhibited distinct bacterial profiles and significant reproductive endocrine changes.
- Fecal microbiota from PCOS patients was enriched in specific bacteria such as Phocaeicola and Mediterraneibacter.
- Transplanted mice showed increased disruption in ovarian function compared to those receiving microbiota from healthy controls.
- Lipo-metabolic disturbances and insulin resistance were observed in recipient mice with PCOS-associated microbiota.
- An obese-like phenotype developed in mice after from PCOS patients.
- The findings indicate a potential link between the gut microbiome and the pathogenesis of PCOS.
AI simplified
Key numbers
25.6
Increase in Body Mass Index
Average BMI in PCOS patients
0.88 ng/ml
Increase in Serum Testosterone Levels
Average testosterone level in PCOS patients
34.3%
Body Fat Percentage
Average body fat percentage in PCOS patients